相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Understanding osteoporosis
M Kassim Javaid et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia
Veronica O'Keane
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Adverse effects of prolactin in rodents and humans: breast and prostate cancer
Philip W. Harvey et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists
Richard IG Holt
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
The impact of hyperprolactinaemia on sexual function in patients with psychosis
Shubulade M Smith
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Prolactin and dopamine: What is the connection? A Review Article
Peter Fitzgerald et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication
Kathleen R. Merikangas et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Prolactin level during 5 years of risperidone treatment in patients with psychotic disorders
J. Eberhard et al.
ACTA PSYCHIATRICA SCANDINAVICA (2007)
Lifetime prevalence of psychotic and bipolar I disorders in a general population
Jonna Perala et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite
Kristina I. Melkersson
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2006)
The relationship between prolactin levels and glucose homeostasis in antipsychotic-treated schizophrenic patients
Oliver D. Howes et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia - Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)
Peter B. Jones et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine
Bruce J. Kinon et al.
PSYCHONEUROENDOCRINOLOGY (2006)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Physical health monitoring of patients with schizophrenia
SR Marder et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Antipsychotic-induced hyperprolactinaemia: Mechanisms, clinical features and management
PM Haddad et al.
DRUGS (2004)
Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study
DE Casey et al.
PSYCHOPHARMACOLOGY (2003)
Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences - Selective literature review
A Wieck et al.
BRITISH JOURNAL OF PSYCHIATRY (2003)
A prospective trial of bupropion SR augmentation of partial and non-responders to Serotonergic antidepressants
C DeBattista et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
The differential effects of atypical Antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: A pharmacological analysis in rats
S Kapur et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone
KS Kim et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis
S Smith et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2002)
Annual cost of bipolar disorder to UK society
R Das Gupta et al.
BRITISH JOURNAL OF PSYCHIATRY (2002)
Review of antipsychotic medication administration: A proposal of intermittent dosing
RA Boshes et al.
SCHIZOPHRENIA BULLETIN (2002)
Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?:: A new hypothesis
S Kapur et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Effects of short and long-term lithium treatment on serum prolactin levels in patients with bipolar affective disorder
M Bastürk et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2001)